VASCULAR DISEASES
Clinical trials for VASCULAR DISEASES explained in plain language.
Never miss a new study
Get alerted when new VASCULAR DISEASES trials appear
Sign up with your email to follow new studies for VASCULAR DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Clot-Busting device tested for emergency lung rescue
Disease control OngoingThis study tests a new device called the Aventus Thrombectomy System to safely remove blood clots from the lungs in people with acute pulmonary embolism. About 130 adults aged 18 to 80 with recent clot symptoms will be treated. The goal is to see if the device improves heart func…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Inquis Medical, Inc. • Aim: Disease control
Last updated May 26, 2026 03:02 UTC
-
Desperate patients get access to Lab-Made blood vessel
Disease control TEMPORARILY_NOT_AVAILABLEThis program offers a lab-grown blood vessel (ATEV) to people with serious vascular disease or kidney failure on dialysis who have no other treatment options and cannot join a clinical study. The vessel is designed to replace or repair damaged blood vessels. The goal is to provid…
Matched conditions: VASCULAR DISEASES
Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated May 26, 2026 03:02 UTC
-
New inhaled drug shows promise for lung scarring and heart strain
Disease control OngoingThis study tests an inhaled medicine called mosliciguat for people with high blood pressure in the lungs caused by scarring lung disease. About 135 adults will receive either the drug or a placebo for 16 weeks. The goal is to see if the drug improves blood flow in the lungs and w…
Matched conditions: VASCULAR DISEASES
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated May 26, 2026 02:54 UTC
-
New hope for PAH patients: Long-Term drug safety trial opens
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called ralinepag for people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. About 1,000 adults who were in earlier ralinepag studies can join. The goal is to see if the drug is …
Matched conditions: VASCULAR DISEASES
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New stent showdown: which device best treats severe heart disease?
Disease control OngoingThis study compares two drug-coated stents (SUPRAFLEX Cruz and SYNERGY) in about 1,550 people with severe blockages in three heart arteries. Participants receive modern heart care including imaging and medications. The goal is to see which stent is safer and more effective at pre…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: National University of Ireland, Galway, Ireland • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Can lower blood pressure save more lives after a stroke?
Disease control OngoingThis study tests whether a lower blood pressure target than the current standard can reduce major heart problems and strokes in people who have already had a stroke. About 4,300 participants will be randomly assigned to either intensive or standard blood pressure control and foll…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New kidney procedure aims to tame stubborn high blood pressure
Disease control OngoingThis study looks at a procedure called renal denervation, which uses energy to calm overactive nerves in the kidneys, to help lower blood pressure in people whose hypertension is not controlled by medication. About 1,900 adults with high blood pressure are taking part. The goal i…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Medtronic Vascular • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Ultrasound zaps blood pressure: new hope for millions?
Disease control OngoingThis study tests a device that uses ultrasound to calm overactive nerves in the kidneys, which can help lower blood pressure. About 282 adults with high blood pressure took part. The goal was to see if the device works better than a fake procedure (sham) to safely reduce blood pr…
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: ReCor Medical, Inc. • Aim: Disease control
Last updated May 19, 2026 11:49 UTC
-
Sound waves vs. high blood pressure: new device aims to replace pills
Disease control OngoingThis study tests a device that uses ultrasound to calm overactive kidney nerves, which can help lower blood pressure. About 154 adults with high blood pressure who are already taking two medications will receive either the ultrasound treatment or a fake procedure. The goal is to …
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Otsuka Medical Devices Co., Ltd. Japan • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
Heart drug study pulled before it even started
Knowledge-focused TerminatedThis study was designed to see if a cholesterol-lowering drug called a PCSK9 inhibitor can also reduce inflammation in the arteries of people with heart disease. Researchers planned to use a special imaging scan to measure inflammation. However, the study was withdrawn before enr…
Matched conditions: VASCULAR DISEASES
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:02 UTC
-
Can a tablet replace a Doctor's office visit for vascular patients?
Knowledge-focused TerminatedThis study aimed to see if virtual clinic visits (using tablets) work as well as in-person visits for people with vascular diseases. Doctors would classify patients' need for treatment after both types of visits to check if the results matched. The study was withdrawn before any …
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: CAMC Health System • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
Hospital study aims to streamline vascular surgery care
Knowledge-focused TerminatedThis study aimed to create a 12-month profile of patients admitted for vascular surgery at an Irish hospital. Researchers planned to measure frailty and other health factors to find ways to improve care and shorten hospital stays. However, the study was withdrawn before enrolling…
Matched conditions: VASCULAR DISEASES
Sponsor: University Hospital of Limerick • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
Diet study for surgery patients pulled before it began
Knowledge-focused TerminatedThis study aimed to see if patients could follow a short-term protein-calorie restriction diet for 4 days before elective vascular surgery. Researchers planned to measure diet compliance and changes in blood markers related to stress and healing. However, the study was withdrawn …
Matched conditions: VASCULAR DISEASES
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 11:59 UTC